{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:37:53Z","timestamp":1790959073770,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772637"],"award-info":[{"award-number":["81772637"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-14086-w","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:23:31Z","timestamp":1761294211000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Targeting FBXL5 to induce ferroptosis and reverse oxaliplatin resistance in iron-rich colorectal cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Miaomiao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"issue":"3","key":"14086_CR1","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S2468-1253(21)00426-X","volume":"7","author":"SG Patel","year":"2022","unstructured":"Patel, S. G. et al. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection[J]. Lancet Gastroenterol. Hepatol. 7 (3), 262\u2013274 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"25","key":"14086_CR2","doi-asserted-by":"publisher","first-page":"e2301088","DOI":"10.1002\/advs.202301088","volume":"10","author":"K Zeng","year":"2023","unstructured":"Zeng, K. et al. Inhibition of CDK1 overcomes oxaliplatin resistance by regulating ACSL4-mediated ferroptosis in colorectal Cancer[J]. Adv. Sci. (Weinh). 10 (25), e2301088 (2023).","journal-title":"Adv. Sci. (Weinh)"},{"issue":"1","key":"14086_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang, C. et al. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance[J]. Mol. Cancer. 21 (1), 47 (2022).","journal-title":"Mol. Cancer"},{"issue":"22","key":"14086_CR4","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1016\/j.molcel.2024.07.020","volume":"84(16)","author":"FG Liang","year":"2024","unstructured":"Liang, F. G. et al. OPA1 promotes ferroptosis by augmenting mitochondrial ROS and suppressing an integrated stress response[J]. Mol. Cell. 84(16) (22), 3098\u20133114e6 (2024).","journal-title":"Mol. Cell."},{"key":"14086_CR5","doi-asserted-by":"publisher","first-page":"103732","DOI":"10.1016\/j.critrevonc.2022.103732","volume":"176","author":"S Wang","year":"2022","unstructured":"Wang, S. et al. Molecular mechanisms of ferroptosis and its role in prostate cancer therapy[J]. Crit. Rev. Oncol. Hematol. 176, 103732 (2022).","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"22","key":"14086_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1126\/sciadv.abg4302","volume":"7","author":"EM Terzi","year":"2021","unstructured":"Terzi, E. M. et al. Iron-sulfur cluster deficiency can be sensed by IRP2 and regulates iron homeostasis and sensitivity to ferroptosis independent of IRP1 and FBXL5[J]. Sci. Adv. 7 (22), 26 (2021).","journal-title":"Sci. Adv."},{"issue":"1","key":"14086_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.molcel.2020.02.011","volume":"78","author":"H Wang","year":"2020","unstructured":"Wang, H. et al. FBXL5 regulates IRP2 stability in iron homeostasis via an Oxygen-Responsive [2Fe2S] Cluster[J]. Mol. Cell. 78 (1), 31\u201341 (2020).","journal-title":"Mol. Cell."},{"issue":"5","key":"14086_CR8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen, X. et al. Broadening horizons: the role of ferroptosis in cancer[J]. Nat. Rev. Clin. Oncol. 18 (5), 280\u2013296 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"16","key":"14086_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/ijms241612928","volume":"24","author":"GJ Kontoghiorghes","year":"2023","unstructured":"Kontoghiorghes, G. J. Iron load toxicity in medicine: from molecular and cellular aspects to clinical Implications[J]. Int. J. Mol. Sci. 24 (16), 18 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"14086_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev-nutr-082117-051732","volume":"38","author":"SV Torti","year":"2018","unstructured":"Torti, S. V. et al. Iron and Cancer[J]. Annu. Rev. Nutr. 38, 97\u2013125 (2018).","journal-title":"Annu. Rev. Nutr."},{"issue":"20","key":"14086_CR11","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.1002\/cam4.4761","volume":"11","author":"T Basak","year":"2022","unstructured":"Basak, T. & Kanwar, R. K. Iron imbalance in cancer: intersection of deficiency and overload[J]. Cancer Med. 11 (20), 3837\u20133853 (2022).","journal-title":"Cancer Med."},{"issue":"4","key":"14086_CR12","first-page":"1143","volume":"54","author":"Y Chen","year":"2019","unstructured":"Chen, Y. et al. Iron metabolism and its contribution to cancer (Review)[J]. Int. J. Oncol. 54 (4), 1143\u20131154 (2019).","journal-title":"Int. J. Oncol."},{"issue":"2","key":"14086_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1615\/JEnvironPatholToxicolOncol.2023049084","volume":"43","author":"Z Wang","year":"2024","unstructured":"Wang, Z. et al. TFR1-Mediated iron metabolism orchestrates tumor ferroptosis and immunity in Non-Small cell lung Cancer[J]. J. Environ. Pathol. Toxicol. Oncol. 43 (2), 1\u201312 (2024).","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"issue":"5","key":"14086_CR14","doi-asserted-by":"publisher","first-page":"e23550","DOI":"10.1096\/fj.202302597R","volume":"38","author":"X Yu","year":"2024","unstructured":"Yu, X. et al. Correlation between ferroptosis and adriamycin resistance in breast cancer regulated by transferrin receptor and its molecular mechanism[J]. FASEB J. 38 (5), e23550 (2024).","journal-title":"FASEB J."},{"issue":"10","key":"14086_CR15","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1039\/C7MT00143F","volume":"9","author":"E Gammella","year":"2017","unstructured":"Gammella, E. et al. The transferrin receptor: the cellular iron gate[J]. Metallomics 9 (10), 1367\u20131375 (2017).","journal-title":"Metallomics"},{"issue":"21","key":"14086_CR16","doi-asserted-by":"publisher","first-page":"4747","DOI":"10.1111\/febs.15266","volume":"287","author":"X Chen","year":"2020","unstructured":"Chen, X. et al. Relieving ferroptosis May partially reverse neurodegeneration of the auditory cortex[J]. FEBS J. 287 (21), 4747\u20134766 (2020).","journal-title":"FEBS J."},{"key":"14086_CR17","doi-asserted-by":"publisher","first-page":"133038","DOI":"10.1016\/j.jhazmat.2023.133038","volume":"465","author":"Q Liu","year":"2024","unstructured":"Liu, Q. et al. A regulatory module comprising G3BP1-FBXL5-IRP2 axis determines sodium arsenite-induced ferroptosis[J]. J. Hazard. Mater. 465, 133038 (2024).","journal-title":"J. Hazard. Mater."},{"issue":"2","key":"14086_CR18","doi-asserted-by":"publisher","first-page":"e51162","DOI":"10.15252\/embr.202051162","volume":"22","author":"J Song","year":"2021","unstructured":"Song, J. et al. The deubiquitinase OTUD1 enhances iron transport and potentiates host antitumor immunity[J]. EMBO Rep. 22 (2), e51162 (2021).","journal-title":"EMBO Rep."},{"issue":"5","key":"14086_CR19","doi-asserted-by":"publisher","first-page":"12021","DOI":"10.1080\/21655979.2022.2054194","volume":"13","author":"H Fan","year":"2022","unstructured":"Fan, H. et al. MiR\u201319a suppresses ferroptosis of colorectal cancer cells by targeting IREB2[J]. Bioengineered 13 (5), 12021\u201312029 (2022).","journal-title":"Bioengineered"},{"issue":"5","key":"14086_CR20","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/s41418-023-01138-9","volume":"30","author":"H Xia","year":"2023","unstructured":"Xia, H. et al. N6-Methyladenosine-modified circSAV1 triggers ferroptosis in COPD through recruiting YTHDF1 to facilitate the translation of IREB2[J]. Cell. Death Differ. 30 (5), 1293\u20131304 (2023).","journal-title":"Cell. Death Differ."},{"issue":"2","key":"14086_CR21","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.molcel.2019.05.020","volume":"75","author":"AK Mayank","year":"2019","unstructured":"Mayank, A. K. et al. An Oxygen-Dependent interaction between FBXL5 and the CIA-Targeting complex regulates iron Homeostasis[J]. Mol. Cell. 75 (2), 382\u2013393 (2019).","journal-title":"Mol. Cell."},{"issue":"2","key":"14086_CR22","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1093\/nar\/gkt935","volume":"42","author":"R Vinas-Castells","year":"2014","unstructured":"Vinas-Castells, R. et al. Nuclear ubiquitination by FBXL5 modulates Snail1 DNA binding and stability[J]. Nucleic Acids Res. 42 (2), 1079\u20131094 (2014).","journal-title":"Nucleic Acids Res."},{"key":"14086_CR23","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/j.biopha.2018.08.119","volume":"107","author":"H Yao","year":"2018","unstructured":"Yao, H. et al. F-box and leucine-rich repeat protein 5 promotes colon cancer progression by modulating PTEN\/PI3K\/AKT signaling pathway[J]. Biomed. Pharmacother. 107, 1712\u20131719 (2018).","journal-title":"Biomed. Pharmacother"},{"issue":"5953","key":"14086_CR24","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1126\/science.1176326","volume":"326","author":"AA Salahudeen","year":"2009","unstructured":"Salahudeen, A. A. et al. An E3 ligase possessing an iron-responsive hemerythrin domain is a regulator of iron homeostasis[J]. Science 326 (5953), 722\u2013726 (2009).","journal-title":"Science"},{"issue":"11","key":"14086_CR25","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1038\/sj.bjc.6602215","volume":"91","author":"D Arango","year":"2004","unstructured":"Arango, D. et al. Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells[J]. Br. J. Cancer. 91 (11), 1931\u20131946 (2004).","journal-title":"Br. J. Cancer"},{"issue":"6","key":"14086_CR26","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3892\/etm.2022.11321","volume":"23","author":"B Liu","year":"2022","unstructured":"Liu, B. & Wang, H. Oxaliplatin induces ferroptosis and oxidative stress in HT29 colorectal cancer cells by inhibiting the Nrf2 signaling pathway[J]. Exp. Ther. Med. 23 (6), 394 (2022).","journal-title":"Exp. Ther. Med."},{"issue":"21","key":"14086_CR27","doi-asserted-by":"publisher","first-page":"5209","DOI":"10.3390\/cancers15215209","volume":"15","author":"X Cheng","year":"2023","unstructured":"Cheng, X. et al. Harnessing ferroptosis to overcome drug resistance in colorectal cancer: promising therapeutic Approaches[J]. Cancers (Basel). 15 (21), 5209 (2023).","journal-title":"Cancers (Basel)"},{"issue":"1","key":"14086_CR28","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/CAD.0000000000001562","volume":"35(6)","author":"R Tao","year":"2024","unstructured":"Tao, R. et al. USP3 promotes cisplatin resistance in non-small cell lung cancer cells by suppressing ACOT7-regulated ferroptosis[J]. Anticancer Drugs. 35(6) (1), 483\u2013491 (2024).","journal-title":"Anticancer Drugs"},{"issue":"7","key":"14086_CR29","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41419-021-03996-y","volume":"12","author":"J Du","year":"2021","unstructured":"Du, J. et al. DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism[J]. Cell. Death Dis. 12 (7), 705 (2021).","journal-title":"Cell. Death Dis."},{"key":"14086_CR30","doi-asserted-by":"publisher","first-page":"153831","DOI":"10.1016\/j.tox.2024.153831","volume":"505","author":"D Jia","year":"2024","unstructured":"Jia, D. et al. NCOA4-mediated ferritinophagy participates in cadmium-triggered ferroptosis in spermatogonia[J]. Toxicology 505, 153831 (2024).","journal-title":"Toxicology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14086-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14086-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14086-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T21:02:53Z","timestamp":1761685373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14086-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14086"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-14086-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"12 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Research Ethics Committee of the Affiliated Hospital of Binzhou Medical College. All study participants provided informed written consent before study enrollment(KYLL\u2212112).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest statement"}},{"value":"Data may be shared at the request of anyqualified investigator for the purposes of replicating procedure and results.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data sharing statement"}},{"value":"The authors have read the ARRIVE guidelines, and the manuscript was prepared and revised according to the ARRIVE guidelines.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Arrive guidelines statement"}}],"article-number":"37189"}}